Further, in order to increase the clinical applicability of our model, we aimed to establish the factors and variables: (e.g.: age, sex, white blood cell count, eGFR value, concentrations of previously tested chemokines, adhesion molecule and inhibitory growth factor) that may influence circulating Neudesin concentration in brain tumor patients. Here, NENF is linked to brain neoplasm.